International Journal of Gynecological Cancer Issues Research Articles in April 2024 Edition
April 02, 2024
April 02, 2024
LONDON, England, April 2 -- The International Journal of Gynecological Cancer, a journal that says it contributes to the study, prevention and treatment of gynaecological cancer from the International Gynecologic Cancer Society and European Society of Gynaecological Oncology, published research articles on the following topics in its April 2024 edition:
Lead Article:
* Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent . . .
Lead Article:
* Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent . . .